Conor McNamara
Stock Analyst at RBC Capital
(1.09)
# 3,802
Out of 5,176 analysts
141
Total ratings
26.8%
Success rate
-14.88%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $52.69 | +38.55% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.11 | +60.77% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $197.37 | +29.20% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.62 | +85.19% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $104.91 | -56.15% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $75.52 | +15.20% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $7.69 | +121.07% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $126.20 | -0.16% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $273.60 | +49.49% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $270.92 | +50.97% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $114.32 | +78.45% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $490.77 | +29.80% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $187.15 | +33.58% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $16.01 | +281.01% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.72 | +48.31% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $52.69
Upside: +38.55%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.11
Upside: +60.77%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $197.37
Upside: +29.20%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.62
Upside: +85.19%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $104.91
Upside: -56.15%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $75.52
Upside: +15.20%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $7.69
Upside: +121.07%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $126.20
Upside: -0.16%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $273.60
Upside: +49.49%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $270.92
Upside: +50.97%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $114.32
Upside: +78.45%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $490.77
Upside: +29.80%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $187.15
Upside: +33.58%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $16.01
Upside: +281.01%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.72
Upside: +48.31%